Medical Treatment & Drug Development
Women's Health
Post-Doctoral Fellowships
Netherlands
Going for the best treatment, thanks to advances in data, genetic and molecular biology techniques
These interventions tend to impose high risks of side effects, while they are typically beneficial in only a small proportion of patients. With recent advances in genetic and molecular biology techniques, a huge number of novel and promising risk markers are identified. Now is the time to evaluate these novel makers and combine them with the conventional risk factors, for a better selection of treatment for patients. If we can develop and validate such multimarker treatment selection rules, only those patients who are likely to benefit will be exposed to the risks of treatment, while alternative interventions can be offered to those unlikely to benefit.
In collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) we have recently developed a multi-marker treatment selection rule for a better choice of treatment in ovarian cancer patients. Within my AXA project, I will work in partnership with EORTC, Institut Curie and Oxford University to validate and extend this decision rule with novel genetic and molecular markers (e.g. folate receptor alpha (FRA), BRCA1
and BRCA2, copy number alterations, and epigenetic changes). Development of this multi-marker treatment selection rule improves the choice of treatment for ovarian cancer patients and avoids exposing them to unnecessary treatment risks, eventually resulting in a better health outcome and quality of life in these patients.
(Scientific title : Applying Novel Markers to Prdict Individualized Risks of and Benefits from tratement in patiens with ovarian cancer)
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Parvin
TAJIK
Institution
Academic Medical Center
Country
Netherlands
Nationality
Iranian
Related articles
Women's Health
AXA Chair
Spain
Understanding Menopause's Effect on Women's Cardiovascular Risk
Cardiovascular disease (CVD) is the leading cause of mortality for women worldwide, yet women remain understudied. Atherosclerosis, the main pathology underlying... Read more
.thumbnail.jpg)
Inés
PINEDA-TORRA
University of Seville
Mental Health & Neurology
Women's Health
Pandemics & Infectious Diseases
AXA Award
Spain
The Effects of the COVID-19 Pandemic on the Mental Health of Mothers and Newborns
Early results are expected in less than 12 months and will help bridge a critical gap in research. Indeed, “in... Read more
Maria
FORASTER
ISGlobal Barcelona Institute for Global Health
Women's Health
Healthcare Systems & Access
Post-Doctoral Fellowship
United Kingdom
Towards timely and quality access to emergency obstetric care in Sub-Saharan Africa
Nearly 300 000 women (1) lose their lives each year from pregnancy-related complications, such as haemorrhage, high blood pressure, obstructed... Read more
Aduragbemi
BANKE-THOMAS